Sign in

CIK 0001598646

  • Non-accelerated filer
  • Smaller reporting company

Minerva Neurosciences, Inc.

Sign in to watch
Ticker
NERV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
260784194
Phone
+1 617-600-7373
Business address
1500 DISTRICT AVENUE, BURLINGTON, MA, 01803
  1. 4 Open-market sale SVP,General Counsel & Sec. sold 17,500 shares at $11.00 ($192,500)
  2. 4 Open-market buy Director bought 50,000 shares at an average $8.12 ($405,750)
  3. 4 Open-market sale EVP, CFO & CBO sold 21,450 shares at an average $11.02 ($236,345)
  4. 4 Open-market sale President & CEO sold 34,281 shares at an average $11.02 ($377,733)
  5. 4 Open-market sale SVP & Chief Operating Officer sold 1,600 shares at $12.03 ($19,248)
  6. 4 Open-market sale SVP,General Counsel & Sec. sold 17,500 shares at $12.00 ($210,000)
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market sale SVP, Chief Accounting Officer sold 17,000 shares at $12.51 ($212,670)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Option exercise Director acquired 202,634 shares (option exercise)
  16. 4 Option exercise Director acquired 202,634 shares (option exercise)
  17. 4 Option exercise 10% owner acquired 202,634 shares (option exercise)
  18. 4 Open-market sale Director sold 1,000,000 shares at $10.00 ($10,000,000)
  19. 4 Open-market sale Director sold 1,000,000 shares at $10.00 ($10,000,000)
  20. 4 Open-market sale 10% owner sold 1,000,000 shares at $10.00 ($10,000,000)

Page 10 of 14 · 264 filings